Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Clinical trial NCT02585778 · COMPLETED
Trial details
- NCT number
- NCT02585778
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-23
- Primary completion
- 2017-04-03
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.